In the REALIZE-K trial, sodium zirconium cyclosilicate increased the rate of mineralocorticoid receptor antagonist treatment optimization for patients with heart failure with reduced ejection fraction.
Read MoreIn the ARREST-AF study, risk factor management improved recurrence rates and symptom burden in patients with atrial fibrillation.
Read MoreIn the My Heart Your Heart trial, research found that reconditioned pacemakers are non-inferior to new pacemakers for patients in lower and middle-income countries.
Read MoreRecent research found cryoballoon and radiofrequency ablation yielded similar arrhythmia outcomes in patients with persistent atrial fibrillation.
Read More
